United States Pharmaceuticals

Aratana Therapeutics Inc (PETX)

Track

Ticker: PETX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 30 Jan 2019
Value US$2,250,307.59 | Price 239.50 | Shares 61,606 (+20.3%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-02-01 2019-01-30 PlS Planned sale
AYRES JOHN C

SEE REMARKS

Officer
61,606 +20.3%
239.50
US$2,250,308 		61,606 +20.3% 239.50 US$2,250,308
2018-12-17 2018-12-17 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
81,801 -2.3%
466.25
US$84,815 		81,801 -2.3% 466.25 US$84,815
2018-11-09 2018-11-07 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
49,501 -30.4%
263.83
US$143,362 		49,501 -30.4% 263.83 US$143,362
2018-11-06 2018-11-02 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
692 -0.4%
6.95
US$4,809 		692 -0.4% 6.95 US$4,809
2018-10-31 2018-10-30 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
11,513 -2.0%
5.86
US$67,454 		11,513 -2.0% 5.86 US$67,454
2018-09-21 2018-09-21 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
75,000 -11.6%
6.06
US$454,305 		75,000 -11.6% 6.06 US$454,305
2018-08-14 2018-08-14 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
1,712 -1.1%
5.15
US$8,817 		1,712 -1.1% 5.15 US$8,817
2018-08-14 2018-08-13 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
8,660 -5.2%
5.15
US$44,599 		8,660 -5.2% 5.15 US$44,599
2018-08-10 2018-08-10 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
1,954 -1.2%
5.15
US$10,063 		1,954 -1.2% 5.15 US$10,063
2018-08-10 2018-08-08 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
2,674 -1.6%
5.15
US$13,771 		2,674 -1.6% 5.15 US$13,771
2018-07-30 2018-07-30 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
11,513 -1.7%
4.33
US$49,842 		11,513 -1.7% 4.33 US$49,842
2018-06-27 2018-06-25 PlS Planned sale Standridge Brent

Chief Operating Officer

Officer
10,000 -9.1%
4.56
US$45,644 		10,000 -9.1% 4.56 US$45,644
2018-02-01 2018-01-30 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
19,367 -2.8%
4.77
US$92,301 		19,367 -2.8% 4.77 US$92,301
2018-01-12 2018-01-11 PlS Planned sale TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
30,000 -28.6%
5.27
US$158,040 		30,000 -28.6% 5.27 US$158,040
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
425,298 -9.0%
5.40
US$2,296,609 		425,298 -9.0% 5.40 US$2,296,609
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,900 -0.0%
5.44
US$10,336 		1,900 -0.0% 5.44 US$10,336
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
5.45
US$272,500 		50,000 -1.0% 5.45 US$272,500
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100 -0.0%
5.47
US$547 		100 -0.0% 5.47 US$547
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
5,110 -0.1%
5.52
US$28,207 		5,110 -0.1% 5.52 US$28,207
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
8,020 -0.2%
5.53
US$44,351 		8,020 -0.2% 5.53 US$44,351
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
72,000 -1.5%
5.65
US$406,800 		72,000 -1.5% 5.65 US$406,800
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
5.90
US$295,000 		50,000 -1.0% 5.90 US$295,000
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
5.95
US$297,500 		50,000 -1.0% 5.95 US$297,500
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -2.0%
5.95
US$595,000 		100,000 -2.0% 5.95 US$595,000
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
11,472 -0.2%
5.97
US$68,488 		11,472 -0.2% 5.97 US$68,488
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100 -0.0%
6.03
US$603 		100 -0.0% 6.03 US$603
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,900 -0.0%
6.26
US$11,894 		1,900 -0.0% 6.26 US$11,894
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
300 -0.0%
6.28
US$1,884 		300 -0.0% 6.28 US$1,884
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
7,700 -0.2%
6.35
US$48,895 		7,700 -0.2% 6.35 US$48,895
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
6.50
US$325,000 		50,000 -1.0% 6.50 US$325,000
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
5,751 -0.1%
6.55
US$37,669 		5,751 -0.1% 6.55 US$37,669
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
49,865 -1.0%
6.60
US$329,109 		49,865 -1.0% 6.60 US$329,109
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,000 -0.0%
6.66
US$6,660 		1,000 -0.0% 6.66 US$6,660
2017-11-13 2017-11-10 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -8.6%
7.00
US$350,000 		50,000 -8.6% 7.00 US$350,000
2017-10-04 2017-10-02 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.9%
6.24
US$312,115 		50,000 -7.9% 6.24 US$312,115
2017-09-27 2017-09-25 PlS Planned sale Standridge Brent

Chief Operating Officer
10,000 -12.5%
6.11
US$61,127 		10,000 -12.5% 6.11 US$61,127
2017-09-19 2017-09-15 PlS Planned sale HEINEN ERNST

Chief Development Officer
10,000 -7.1%
6.25
US$62,500 		10,000 -7.1% 6.25 US$62,500
2017-04-18 2017-04-17 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.9%
5.54
US$277,150 		50,000 -7.9% 5.54 US$277,150
2017-01-31 2017-01-27 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.3%
7.72
US$385,875 		50,000 -7.3% 7.72 US$385,875
2016-12-16 2016-12-15 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -8.4%
7.63
US$381,380 		50,000 -8.4% 7.63 US$381,380
2016-10-04 2016-10-03 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
10,000 -8.0%
10.00
US$100,006 		10,000 -8.0% 10.00 US$100,006
2016-09-12 2016-09-09 PlS Planned sale TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
30,000 -29.3%
9.25
US$277,599 		30,000 -29.3% 9.25 US$277,599
2016-08-10 2016-08-09 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.2%
9.25
US$462,500 		50,000 -7.2% 9.25 US$462,500
2016-06-28 2016-06-28 PlS Planned sale STEPHANUS JULIA A

CHIEF COMMERCIAL OFFICER

Officer
30,000 -19.0%
6.25
US$187,500 		30,000 -19.0% 6.25 US$187,500
2016-06-17 2016-06-17 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
25,000 -3.5%
6.32
US$158,020 		25,000 -3.5% 6.32 US$158,020
2016-06-17 2016-06-16 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
75,000 -9.5%
6.24
US$468,292 		75,000 -9.5% 6.24 US$468,292
2016-06-13 2016-06-10 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
15,000 -10.7%
6.72
US$100,862 		15,000 -10.7% 6.72 US$100,862
2016-02-02 2016-02-01 PlS Planned sale TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
2,806 -2.7%
3.36
US$9,436 		2,806 -2.7% 3.36 US$9,436
2015-04-28 2015-04-27 PlS Planned sale Rhodes Linda

CHIEF SCIENTIFIC OFFICER

Officer
3,300 -0.8%
15.78
US$52,073 		3,300 -0.8% 15.78 US$52,073
2015-04-28 2015-04-27 PlS Planned sale Rhodes Linda

CHIEF SCIENTIFIC OFFICER

Officer
11,700 -2.7%
14.78
US$172,912 		11,700 -2.7% 14.78 US$172,912
2015-01-06 2015-01-02 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
25,000 -3.5%
17.87
US$446,648 		25,000 -3.5% 17.87 US$446,648
2014-03-12 2014-03-10 S Sale MPM BIOVENTURES V, L.P. Large shareholder
600,000 -17.9%
20.02
US$12,012,000 		600,000 -17.9% 20.02 US$12,012,000
2014-03-11 2014-03-07 S Sale Foley Todd Large shareholder
12,539 -100.0%
19.95
US$250,153 		12,539 -100.0% 19.95 US$250,153
2014-03-11 2014-03-07 S Sale GADICKE ANSBERT Large shareholder
26,713 -100.0%
20.16
US$538,534 		26,713 -100.0% 20.16 US$538,534
2014-02-05 2014-02-03 S Sale MEEUSEN RONALD L Non-Executive Director
45,100 -37.4%
19.00
US$856,900 		45,100 -37.4% 19.00 US$856,900
2014-02-05 2014-02-03 S Sale MEEUSEN RONALD L Non-Executive Director
454,900 -37.4%
19.00
US$8,643,100 		454,900 -37.4% 19.00 US$8,643,100
2014-02-05 2014-02-03 S Sale Avalon Ventures IX, L.P. Large shareholder
825,000 -19.8%
19.00
US$15,675,000 		825,000 -19.8% 19.00 US$15,675,000
2014-02-05 2014-02-03 S Sale Lichter Jay Non-Executive Director Large shareholder
825,000 -19.8%
19.00
US$15,675,000 		825,000 -19.8% 19.00 US$15,675,000
2013-07-03 2013-07-02 B Purchase St Peter Steven

PRESIDENT AND CEO

Executive Director
8,333 +1.6%
6.00
US$49,998 		8,333 +1.6% 6.00 US$49,998
2013-07-03 2013-07-02 B Purchase STEPHANUS JULIA A

CHIEF COMMERCIAL OFFICER

Officer
2,000 +1.5%
6.00
US$12,000 		2,000 +1.5% 6.00 US$12,000
2013-07-02 2013-07-02 B Purchase Vander Vort John Non-Executive Director Large shareholder
500,000 +13.0%
6.00
US$3,000,000 		500,000 +13.0% 6.00 US$3,000,000
2013-07-02 2013-07-02 B Purchase MPM BIOVENTURES V, L.P. Large shareholder
500,000 +13.0%
6.00
US$3,000,000 		500,000 +13.0% 6.00 US$3,000,000
Explore more

More insider trading research around Aratana Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America